Cite
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.
MLA
Babačić, Haris, et al. “CRISPR-Cas Gene-Editing as Plausible Treatment of Neuromuscular and Nucleotide-Repeat-Expansion Diseases: A Systematic Review.” PLoS ONE, vol. 14, no. 2, Feb. 2019, pp. 1–32. EBSCOhost, https://doi.org/10.1371/journal.pone.0212198.
APA
Babačić, H., Mehta, A., Merkel, O., & Schoser, B. (2019). CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review. PLoS ONE, 14(2), 1–32. https://doi.org/10.1371/journal.pone.0212198
Chicago
Babačić, Haris, Aditi Mehta, Olivia Merkel, and Benedikt Schoser. 2019. “CRISPR-Cas Gene-Editing as Plausible Treatment of Neuromuscular and Nucleotide-Repeat-Expansion Diseases: A Systematic Review.” PLoS ONE 14 (2): 1–32. doi:10.1371/journal.pone.0212198.